Dworzak et al., performed complex analyses, including both in vivo and in vitro AD models, starting from the assumption that CX3CR1 can be expressed by neurons and microglia in some contexts, having different influences on the local response to Aβ deposition. This evidence concerns the gene CX3CR1 and Alzheimer disease.